 CD4 Lymphocyte Count
"CD4 Lymphocyte Count" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer.
| Descriptor ID |
D018791
|
| MeSH Number(s) |
E01.370.225.500.195.107.595.500.150 E01.370.225.625.107.595.500.150 E05.200.500.195.107.595.500.150 E05.200.625.107.595.500.150 E05.242.195.107.595.500.150 G04.170.107.595.500.150 G09.188.105.595.500.150
|
| Concept/Terms |
CD4 Lymphocyte Count- CD4 Lymphocyte Count
- Lymphocyte Count, CD4
- CD4 Lymphocyte Counts
- Lymphocyte Counts, CD4
- CD4 Counts
- CD4 Count
- CD4 Cell Counts
- CD4 Cell Count
- CD4+ Cell Counts
- CD4+ Cell Count
- CD4+ Counts
- CD4+ Count
- T4 Lymphocyte Count
- Count, T4 Lymphocyte
- Counts, T4 Lymphocyte
- Lymphocyte Count, T4
- Lymphocyte Counts, T4
- T4 Lymphocyte Counts
|
Below are MeSH descriptors whose meaning is more general than "CD4 Lymphocyte Count".
Below are MeSH descriptors whose meaning is more specific than "CD4 Lymphocyte Count".
This graph shows the total number of publications written about "CD4 Lymphocyte Count" by people in UAMS Profiles by year, and whether "CD4 Lymphocyte Count" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 0 | 1 | 1 | | 2018 | 0 | 1 | 1 | | 2016 | 0 | 1 | 1 | | 2014 | 0 | 2 | 2 | | 2013 | 0 | 4 | 4 | | 2012 | 0 | 1 | 1 | | 2011 | 1 | 0 | 1 | | 2010 | 0 | 4 | 4 | | 2009 | 0 | 1 | 1 | | 2008 | 0 | 2 | 2 | | 2007 | 0 | 4 | 4 | | 2006 | 0 | 1 | 1 | | 2003 | 0 | 2 | 2 | | 2002 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "CD4 Lymphocyte Count" by people in Profiles over the past ten years.
-
Rajdev L, Jackie Wang CC, Joshi H, Lensing S, Lee J, Ramos JC, Baiocchi R, Ratner L, Rubinstein PG, Ambinder R, Henry D, Streicher H, Little RF, Chiao E, Dittmer DP, Einstein MH, Cesarman E, Mitsuyasu R, Sparano JA. Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study. Cancer. 2024 03 15; 130(6):985-994.
-
Ramos JC, Sparano JA, Chadburn A, Reid EG, Ambinder RF, Siegel ER, Moore PC, Rubinstein PG, Durand CM, Cesarman E, Aboulafia D, Baiocchi R, Ratner L, Kaplan L, Capoferri AA, Lee JY, Mitsuyasu R, Noy A. Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood. 2020 09 10; 136(11):1284-1297.
-
Xu W, Luo Z, Alekseyenko AV, Martin L, Wan Z, Ling B, Qin Z, Heath SL, Maas K, Cong X, Jiang W. Distinct systemic microbiome and microbial translocation are associated with plasma level of anti-CD4 autoantibody in HIV infection. Sci Rep. 2018 08 27; 8(1):12863.
-
Davids MS, Kim HT, Bachireddy P, Costello C, Liguori R, Savell A, Lukez AP, Avigan D, Chen YB, McSweeney P, LeBoeuf NR, Rooney MS, Bowden M, Zhou CW, Granter SR, Hornick JL, Rodig SJ, Hirakawa M, Severgnini M, Hodi FS, Wu CJ, Ho VT, Cutler C, Koreth J, Alyea EP, Antin JH, Armand P, Streicher H, Ball ED, Ritz J, Bashey A, Soiffer RJ. Ipilimumab for Patients with Relapse after Allogeneic Transplantation. N Engl J Med. 2016 Jul 14; 375(2):143-53.
-
Sanou M, Soubeiga ST, Bationo F, Compaore TR, Zohoncon TM, Diatto GN, Ouedraogo P, Pietra V, Nagalo BM, Bisseye C, Traore RO, Simpore J. A decade of follow-up and therapeutic drug monitoring in HIV-2 immunocompromised patients at St Camille and General Lamizana Military Medical Centers, Burkina Faso, West Africa. Pak J Biol Sci. 2014 Dec; 17(12):1219-24.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|